Magnesium and the heart: antiarrhythmic therapy with magnesium (Q40795208)

23 September 2017

1 reference

title

Magnesium and the heart: antiarrhythmic therapy with magnesium (English)

1 reference

23 September 2017

0 references

Fazekas T

1

1 reference

23 September 2017

Scherlag BJ

2

1 reference

23 September 2017

Vos M

3

1 reference

23 September 2017

Wellens HJ

4

1 reference

23 September 2017

Lazzara R

5

1 reference

23 September 2017

1 November 1993

1 reference

23 September 2017

1 reference

23 September 2017

16

1 reference

23 September 2017

11

1 reference

23 September 2017

768-774

1 reference

Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion

23 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

Magnesium deficiency in coronary artery disease and cardiac arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

Magnesium Therapy in Ventricular Arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

Magnesium substitution in acute ischaemic heart syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

Magnesium in cardiac energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Clinical significance of magnesium: a review.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium ions in cardiac function. Regulator of ion channels and second messengers

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Effect of magnesium chloride on electrical stability of the heart

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Effects of an increase in intracellular free [Mg2+] after myocardial stunning on sarcoplasmic reticulum Ca2+ transport

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Monophasic action potentials in the diagnosis of triggered arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Torsade de pointes and magnesium deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Myocardial magnesium: relation to laboratory and clinical variables in patients undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium deficiency and sudden death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium, myocardial ischaemia and arrhythmias. The role of magnesium in myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Organophosphates and torsade de pointes ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

The role of magnesium in cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Is hypomagnesemia or magnesium deficiency arrhythmogenic?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Effect of tetraethylammonium, 4-aminopyridine, cesium and magnesium on slow responses in the guinea pig papillary muscle

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Effect of the infusion of magnesium sulfate during atrial pacing on ECG intervals, serum electrolytes, and blood pressure.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

The Role of Triggered Activity in Clinical Ventricular Arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium sulfate and digitalis-toxic arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Torsades de pointes: prevention and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Studies on magnesium's mechanism of action in digitalis-induced arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Suppression of ventricular arrhythmias by magnesium

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Termination of ouabain-induced ventricular tachycardia by flunarizine in conscious dogs

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Intravenous magnesium in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Importance of magnesium chloride repletion after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium sulfate is the treatment for torsades de pointes if the right dose is given

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Torsade de pointes ventricular tachycardia associated with lidoflazine therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Effect of intravenous magnesium sulfate on supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium sulfate and chloride in suppression of ectopic ventricular tachycardia accompanying acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161105

7 January 2021

Identifiers

DOI

10.1002/CLC.4960161105

1 reference

23 September 2017

1 reference